The Clap
Illumina has been given green light to acquire cancer detection company Grail Inc.
More on Illumina
Illumina develops, manufactures, & markets integrated systems for large-scale analysis of genetic variation & function.
The Deets
A U.S. judge ruled that the acquisition would not hurt competition, something the Biden administration has been pushing to tackle.
So What
The $7.1 billion deal has been on hold for a year now, as the U.S. competition watchdog, the Federal Trade Commission (FTC), filed a lawsuit against Illumina.
Now What
The FTC could turn to another official commission, which has the power to overturn the judge’s decision.
